Medasense Launches New Pain Monitoring Device, PMD200 following European CE approval - January 2017

PMD-200 CE Approval

18 Jan 2017 News and Events

Medasense Biometrics Ltd. announced today that it has received CE mark approval for its novel Pain Monitoring Device, PMD200.
This new technology is now available to help physicians objectively assess a patient’s pain in critical care situations, where

patients are unable to communicate.  This allows physicians to ensure pain is properly managed.

To read the full PR click here.